You have searched for "regulatory"
Showing 11-20 of 4639
(Adds EXPLAINER to media identifier)
ISKANDAR PUTERI: Malaysia will make a decision on the AstraZeneca Covid-19 vaccine tomorrow (April 6), but says it has a back-up plan in case it needs to defer its use.
KOTA KINABALU: The Health Ministry will continue with plans to use the AstraZeneca Covid-19 vaccine as the benefits outweigh the reported adverse effects, says director-general Tan Sri Dr Noor Hisham Abdullah.
ISKANDAR PUTERI: Malaysia will decide on the use of the AstraZeneca Covid-19 vaccine following cases of blood clots and deaths in the United Kingdom.
How can we ensure water security – sustainable and sufficient quantities of quality water – through the years?
GEORGE TOWN: Malaysia will stick with the AstraZeneca Covid-19 vaccine for now until there is data to prove the vaccine produces a lot of adverse effects.
SERDANG (Bernama): About one in 28 Covid-19 vaccine recipients have experienced side effects but these are largely minor complaints, says Health Minister Datuk Seri Dr Adham Baba.
(Reuters) - Moderna Inc on Thursday received approval from the U.S. Food and Drug Administration (FDA) for an additional multi-dose vial of its COVID-19 vaccine in which each vial contains a maximum of 15 doses, increasing the number of doses available.
CHICAGO (Reuters) - The United States may not need AstraZeneca's COVID-19 vaccine, even if it wins U.S. regulatory approval, Anthony Fauci, the nation's top infectious disease doctor told Reuters on Thursday.
Pfizer/BioNTech COVID-19 shot 91% effective in updated data, protective against South African variant
(Reuters) - Pfizer Inc and BioNTech said on Thursday their vaccine is around 91% effective at preventing COVID-19, citing updated trial data that included participants inoculated for up to six months.